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Serotonin is best known as a neuro-
transmitter in the brain. Released by one
neuron and picked up by another, it
regulates mood and aggression. Many
antidepressants, and the party drug Ecsta-
sy, increase serotonin stimulation. But it is
found outside the central nervous system
as well, including in the pancreas, specif-
ically in the beta cells that release insulin
to regulate blood glucose levels. Serotonin
was discovered in beta cells over 30 years
ago, and researchers have been trying to
figure out what it’s doing there ever since.
In a new study, Nils Paumann, Diego
Walther, and colleagues show that seroto-
nin plays a key role in controlling insulin
secretion and that its absence leads to
diabetes. Even more surprisingly, it does
so through a completely different mecha-
nism than that used in the brain—it acts
within, not between, cells and, rather than
forming brief and weak liaisons with a
receptor, makes long-lasting covalent
bonds with an enzyme.
When released from the pancreas,
insulin helps other cells in the body take
up sugar from the bloodstream, feeding
the cells and bringing blood sugar levels
down again. Diabetes, in its several forms,
arises when the system goes awry. Before
its release, insulin is stored in beta cells in
secretory granules. These granules also
store serotonin, which is released along
with insulin. (In fact, when cell biologists
want to track insulin release, they often
measure serotonin instead because it’s
easier to monitor.)
Prior studies have offered some clues to
serotonin’s activities in other tissues in the
body’s periphery. In platelet-forming cells
called thrombocytes, it links up to a group
of signaling enzymes called GTPases,
triggering the release of vesicle contents
by exocytosis. Unlike the fleeting connec-
tions it makes to receptors within the brain,
serotonin covalently bonds to the GTPase,
a reaction called ‘‘serotonylation,’’ which is
catalyzed by a transglutaminase enzyme.
Intriguingly, GTPases also help regulate
insulin secretion in the pancreas, and lack
of transglutaminase leads to glucose intol-
erance, both suggesting that the same
system may be at play in the pancreas.
To test this directly, the authors exam-
ined mice lacking tryptophan hydroxylase,
a key enzyme in serotonin synthesis,
rendering the mice unable to make
serotonin outside the central nervous
system. The mice exhibited classic signs
of diabetes—elevated blood glucose and
decreased insulin secretion. They were
also resistant to the effects of pargyline, a
chemical that in normal mice causes
insulin release, suggesting that the absence
of serotonin blocked this effect. Infusion of
serotonin normalized secretion in mice
unable to make their own.
The authors found that serotonin in
pancreatic cells bound directly to GTPase
enzymes, and by blocking transglutamin-
ase, blocked this reaction, reducing insulin
secretion. The authors identified two
specific GTPases that are known to play
a role in insulin secretion as targets for
serotonylation. But, based on the large
amount of protein-bound serotonin they
saw, they suggest serotonin likely links up
with multiple other proteins as well,
suggesting a host of other interactions yet
to be discovered.
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Sugar and mice that were unable to make serotonin helped identify a link between
diabetes mellitus and the ‘‘feel-good’’ hormone serotonin.
doi:10.1371/journal.pbio.1000227.g001
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suggests that by binding to GTPases,
serotonin promotes insulin release in
response to elevated glucose. In addition
to solving the puzzle of what a brain
neurotransmitter is doing in the pancreas,
the study has some important clinical
implications. The condition that devel-
oped in the mice lacking tryptophan
hydroxylase most resembled the human
form of disease known as ‘‘maturity onset
diabetes of the young,’’ raising the intrigu-
ing prospect that this disease may be
linked to mutation of the tryptophan
hydroxylase gene, a possibility that will
require further study. Whether or not this
is so, the serotonin pathway provides an
avenue for intervention in multiple forms
of diabetes, since it directly influences the
amount of insulin secreted. Given the
medical importance of diabetes—it affects
almost 200 million people worldwide, and
requires chronic treatment—it is a good
bet that serotonin modulation will soon be
a target for drug development.
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